Reporting Causes High Blood Pressure...And Lowers It

  • by: |
  • 02/27/2007
Some of the worst reporting on health surrounds the relative and absolute risks and benefits about medicines. Case in point is the HPV vaccine. As our friend NYU internist and author Mark Siegel points out, the reason for making the vaccine mandatory has less to do with reducing cancer, important on its own, but also genital herpes, abnormal pap smears and other public health problems...

"The problem with combating the human papilloma virus in the United States isn't only cervical cancer or precancerous cells. The problem also is an epidemic of sexually transmitted genital warts. The CDC says HPV causes more than 6 million new cases of genital warts in this country every year.

There are many cases in medical history where vaccination has proved extremely effective in promoting public health even in the face of possible side effects."
http://www.newsday.com/news/printedition/opinion/ny-opsie205101066feb20,0,3529854.story?coll=ny-opinion-print

The coverage of a recent data dredging effort looking at the RELATIVE RISKS of taking different painkillers and high blood pressures for the most part failed to make the qualifications the researchers did. (This was a study of heavy, obese males in the main who were frequent users of all sorts of pain killers against non users that did not control for any other medications) The increase in risk of 33 percent was an increase in risk from 1 percent to 1.36 percent. Leave to scaremonger at the Washington Post
Shankar Vedantam to write a story with the headline : Doctors Warned About Common Drugs for Pain NSAIDs Tied to Risk of Heart Attack, Stroke... Aargh..

But Seniorjournal.com saves the day with straightforward reporting that just gives the facts without the unscientific spin that shady Shankar always seems to give to his stories:

Older Men Regularly Taking Over-the-Counter Pain Relievers have Risk of High Blood Pressure

http://www.seniorjournal.com/NEWS/Health/2007/7-02-26-OlderMenRegularly.htm
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog